Literature DB >> 305939

Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.

K D Elgert, W L Farrar.   

Abstract

Spleen cells from mice bearing methylcholanthrene-induced fibrosarcomas impaired mitogen responses of normal syngeneic lymphocytes. Nylon wool column and other depletion techniques were utilized to characterize the cellular source of suppressive activity in tumor-bearing host (TBH) spleens. Evidence is presented for two distinct suppressor cell systems operating in the spleens, but not lymph nodes, of BALB/c mice bearing transplanted tumors. Spleens from TBH were shown to have greatly increased numbers of macrophages over their normal counterparts. TBH macrophages were observed to have suppressive activity at low in vitro concentrations. Anti-Thy 1 serum treatment of TBH macrophages abrogated low dose inhibition but not suppression due to high numbers of macrophages. No functional difference was detected between anti-Thy 1 serum-treated TBH and normal splenic macrophages. In a macrophage-depleted culture system, mildly nylon wool adherent, anti-Thy 1 serum, and hydrocortisone succinate-sensitive suppressor cells could be detected. Soluble supernatant products of TBH spleen and thymus cells were also found to inhibit in vitro mitogen responses, whereas TBH macrophages and lymph node cells demonstrated no soluble suppressive activity. The major source of soluble inhibitor of DNA synthesis (IDS) seems to be an anti-Thy 1 serum, hydrocortisone-sensitive population.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 305939

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells.

Authors:  A D Yurochko; P S Nagarkatti; M Nagarkatti; K D Elgert
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Progressive splenomegaly with increasing extramedullary haematopoiesis in subcutaneous 9L-glioma bearing rats.

Authors:  H Imaya; M Kudo; H Matsuura
Journal:  Int J Exp Pathol       Date:  1993-02       Impact factor: 1.925

3.  Generation of suppressor cells in mice after surgical trauma.

Authors:  B S Wang; E H Heacock; A V Wu; J A Mannick
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

4.  Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor.

Authors:  Q W Ye; M B Mokyr; J M Pyle; S Dray
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  Suppression of delayed-type hypersensitivity mediated by macrophage-like cells in mice with experimental liver injury.

Authors:  S Tajima; N Nishimura; K Ito
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

6.  Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources.

Authors:  S K Gregorian; J R Battisto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Kinetics of the reactivity of subpopulations of spleen cells of mice bearing virus-induced mammary tumors to syngeneic antigenic extracts in vitro. Supportive and suppressive effects of macrophages.

Authors:  C A Laing
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

8.  Interleukin 2 activity in peripheral blood mononuclear cells of patients with gynecologic malignancies.

Authors:  Y Kikuchi; T Kita; K Oomori; M Miyauchi; I Iwano; I Kizawa
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

9.  T cell recruitment from the thymus to the spleen in tumor-bearing mice. I. Analysis of recruited cells by surface markers.

Authors:  K Tanaka; Y Koga; K Taniguchi; K Kamikaseda; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  Modulation of the immunosuppressive effects of splenic macrophages in Fischer rats bearing adenocarcinoma 13762.

Authors:  J Bonaventure; V N Nigam; C A Brailovsky
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.